We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
In brief.
- Abstract
Reports on news items concerning science and industries as of September 2005. U.S. Food and Drug Administration's approval of a genetic test that identifies patients who are at increased risk of suffering side effects from a drug commonly used to treat colon cancer; OSI Pharmaceuticals' takeover of Eyetech Pharmaceuticals, maker of the drug Macugen for people with age-related macular degeneration; China National Petroleum's purchase of PetroKazakhstan.
- Subjects
UNITED States; SCIENCE; INDUSTRIES; HUMAN chromosome abnormality diagnosis; OSI Pharmaceuticals Inc.; EYETECH Pharmaceuticals Inc.; CHINA National Petroleum Corp.; PETROKAZAKHSTAN Inc.; PHARMACEUTICAL industry; PETROLEUM industry; MERGERS &; acquisitions
- Publication
Nature, 2005, Vol 437, Issue 7055, p25
- ISSN
0028-0836
- Publication type
Article
- DOI
10.1038/437025a